Biorestorative Therapies - 53 Year Dividend History | BRTX
Historical dividend payout and yield for Biorestorative Therapies (BRTX) since 1971. The current TTM dividend payout for Biorestorative Therapies (BRTX) as of November 19, 2024 is $0.00. The current dividend yield for Biorestorative Therapies as of November 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.010B |
$0.000B |
|
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The company's core programs consist of Disc/Spine Program and Metabolic Program. Disc/Spine Program consists of cell therapy candidate, brtxDISC(TM) is a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow. Metabolic Program consists of ThermoStem(R), developing an allogeneic cell-based therapy to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. BioRestorative Therapies, Inc. is based in Melville, New York.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
